Feb 29

ZURICH (Reuters) - AstraZeneca Plc's nexium drug has been approved in the United States for treating excess stomach acid in children aged 1 to 11, the Food and Drug Administration (FDA) said on Thursday.

the FDA approved Nexium, Astra's most honorable position seller and the world's second-biggest prescription medicine, in two forms — a delayed response pericarp and a liquid — it said in a statement.

It was approved in a dose of 10 milligrams, or 20mg diurnal, for children aged between 1 and 11, half the dosage for patients aged 12 to 17.

(Reporting by Sam Cage; Editing by David Holmes)

Leave a Reply

  • effexor
  • zithromax
  • prednisone
  • phentrimine